OLMASTRONI, ELENA
OLMASTRONI, ELENA
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Operational Definitions of Polypharmacy and Their Association with All-Cause Hospitalization Risk: A Conceptual Framework Using Administrative Databases
2025 S. Scotti, L. Scotti, F. Galimberti, S. Xie, M. Casula, E. Olmastroni
Longevity-associated BPIFB4 gene counteracts the inflammatory signaling.
2024 M. Cattaneo, A. Baragetti, A. Malovini, E. Ciaglia, V. Lopardo, E. Olmastroni, M. Casula, C. Ciacci, A. Catapano, A. Puca
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries
2024 A. Alieva, A. Di Costanzo, M. Gazzotti, O. Reutova, E. Usova, V. Bakaleiko, M. Arca, L. D'Erasmo, F. Pellegatta, F. Galimberti, E. Olmastroni, A. Catapano, M. Casula
Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials
2024 S. Xie, F. Galimberti, E. Olmastroni, T.F. Luscher, S. Carugo, A.L. Catapano, M. Casula, C. Wanner, S. Yusuf, A. Maggioni, A. Kirby, H. Ogawa, E.K. Hoogeveen, I. Seljeflot, K. Welty, M. Benderly, J.E. Manson, K. Wolski, C.P. Cannon, F.J. Raal, D. Kallend, J. Foody, M. Louie
A newly developed method for assessing co-exposure to free dose combinations: a proof-of-concept study using antihypertensive medications in Danish registers
2024 M. Antonietta Barbieri, S. Marie Neumann Nielsen, A. Rossi, E. Olmastroni, M. Casula, E. Spina, M. Sessa
Plasma proteins associate with carotid plaques and predict incident atherosclerotic cardiovascular events
2024 A. Baragetti, L. Grigore, E. Olmastroni, E. Mattavelli, A. Catapano
Effect on C‐reactive protein levels of the addition of ezetimibe, bempedoic acid, or colchicine to statin treatment: A network meta‐analysis
2024 S. Xie, F. Galimberti, E. Olmastroni, A.L. Catapano, M. Casula
Ezetimibe: Integrating Established Use with New Evidence - A Comprehensive Review
2024 E. Olmastroni, S. Scotti, F. Galimberti, S. Xie, M. Casula
Approaches to Deprescribing Proton Pump Inhibitors in Clinical Practice: A Systematic Review
2024 A. Rossi, L. Perrella, S. Scotti, E. Olmastroni, F. Galimberti, I. Ardoino, V. Orlando, E. Menditto, C. Franchi, M. Casula
Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment
2023 F. Galimberti, M. Casula, E. Olmastroni
Adherence to Mediterranean Diet: A Population-Based Longitudinal Cohort Study
2023 E. Mattavelli, E. Olmastroni, M. Casula, L. Grigore, F. Pellegatta, A. Baragetti, P. Magni, A.L. Catapano
Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review
2023 E. Olmastroni, F. Galimberti, E. Tragni, A.L. Catapano, M. Casula
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study
2023 M. Casula, M. Gazzotti, M.E. Capra, E. Olmastroni, F. Galimberti, A.L. Catapano, C. Pederiva
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia
2023 E. Olmastroni, M. Gazzotti, M. Averna, M. Arca, P. Tarugi, S. Calandra, S. Bertolini, A.L. Catapano, M. Casula
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group
2022 C. Pederiva, M.E. Capra, G. Biasucci, G. Banderali, E. Fabrizi, M. Gazzotti, M. Casula, A.L. Catapano, M. Arca, M. Averna, S. Bertolini, S. Calandra, P. Tarugi, F. Pellegatta, A. Marcello, A. Maurizio, B. Andrea, B. Giacomo, B. Claudio, C. Paolo, C. Francesca, C. Francesco, C. Nadia, Maria Del Ben, F. Giuliana, G. Ornella, I. Arcangelo, I. Gabriella, I. Lorenzo, M. Giuseppe, M. Lorenzo, G.G. Mombelli, M. Sandro, P. Gianfranco, P. Angelina, C.A. Pederiva, P. Livia, P. Arturo, P. Francesco, Anna Rita Roscini, S. Riccardo, S. Patrizia, Josè Pablo Werba, Z. Sabina, Maria Grazia Zenti, A. Massimiliano, A. Renata, B. Davide, B. Giuseppe, B. Patrizia, B. Marco, Paola Sabrina Buonuomo, Angelo Baldassarre Cefalù, C. Giuseppe, D. Sergio, Maria Donata Di Taranto, F. Roberto, F. Fabio, G. Simonetta, G. Liliana, L. Graziana, M. Sara, G. Massini, M. Ilenia, M. Tiziana, N. Fabio, C. Pavanello, Francesco Massimo Perla, P. Gaia, S. Elena, S. Roberto, T. Arianna, Giovanni Battista Vigna, Z. Alberto, M. Casula, F. Galimberti, M. Gazzotti, E. Olmastroni, V. Zampoleri
Evaluation of Factors Associated With Appropriate Drug Prescription and Effectiveness of Informative and Educational Interventions-The EDU.RE.DRUG Project
2022 F. Galimberti, E. Olmastroni, M. Casula, I. Merlo, M. Franchi, A. Luigi Catapano, V. Orlando, E. Menditto, E. Tragni, O.B.O.E.R. DRUG Group
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group
2022 M. Gazzotti, M. Casula, S. Bertolini, M.E. Capra, E. Olmastroni, A.L. Catapano, C. Pederiva
USE OF MENDELIAN RANDOMIZATION STUDIES TO IDENTIFY POSSIBLE PHARMACOLOGICAL TARGETS IN THE CARDIOVASCULAR AREA
2022 E. Olmastroni
Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies
2022 M. Casula, F. Galimberti, M. Iommi, E. Olmastroni, S. Rosa, M. Altini, A.L. Catapano, E. Tragni, E. Poluzzi
Antibiotic Prescription in the Community-Dwelling Elderly Population in Lombardy, Italy: A Sub-Analysis of the EDU.RE.DRUG Study
2022 F. Galimberti, M. Casula, E. Olmastroni, A.L. Catapano, E. Tragni